Sequence-specific DNA ligands that antagonize DNA-protein interactions represent a potentially powerful means of modulating gene expression. Calicheamicin -il, a member of the DNA-cleaving enedlyne class of anticancer antibiotics, binds to specific DNA sequences through an aryltetrasaccharide domain. To take advantage of this unique sequence-specific recognition capability, the methyl glycoside of the aryltetrasaccharide of caliche min yi (CLM-MG) was used to investigate the ability of glycoconjugate DNA ligands to inhibit DNA-protein interactions. CLM-MG inhibits the formation of DNA-protein complexes at micromolar concentrations in a sequence-specific manner and rapidly dissociates preformed complexes. CLM-MG also inhibits transcription in vivo with similar sequence specificity. These results suggest a strategy for the development of a class of novel biological probes and therapeutic agents.The ordered regulation of gene expression underlying specific developmental programs or cellular responses to physiologic stimuli relies on sequence-specific DNA-protein interactions (1). This requisite DNA sequence specificity suggests a means to control cellular responses through the use of DNA ligands that interfere with these specific DNA-protein interactions. To be biologically useful such ligands would need to (i) bind DNA with a high degree of sequence specificity, (ii) antagonize DNA-protein interactions either by inhibition of DNA-protein complex formation or by displacement of preformed complexes, and (iii) exhibit sufficient hydrophobicity to pass through cell membranes and thereby function in vivo. Several types of DNA ligands have been shown to satisfy some of these criteria, including oligodeoxynucleotides involved in triple-helix formation (2, 3), peptide nucleic acids (4), and nonintercalating minor groove DNA ligands such as netropsin and distamycin A (5). However, none of these adequately satisfy all the requirements for specific and biologically useful transcriptional antagonists.The enediyne compound calicheamicin 'yI (CLM; Fig. 1A), representative of a class of enediyne glycoconjugate DNA ligands, binds to and cleaves DNA at specific 4-bp sequences. Double-strand DNA cleavage occurs through bioreduction of the trisulfide and subsequent 1,4-benzenoid diradical formation, which results in hydrogen abstraction from adjacent nucleotide bases (10-13). Affinity cleavage experiments (7,8) MATERIALS AND METHODS Preparation of Nuclear Extracts and DNA-Bhin Assays. Nuclear extracts were prepared as previously described (19) from TAg Jurkat cells (20) stimulated for 2 hr with 2 pM ionomycin plus phorbol 12-tetradecanoate 13-acetate (PTA) at 20 ng/ml, HeLa cells stimulated for 2 hr with PTA at 20 ng/ml, or MDCK cells. CLM-MG was solubilized in 10% (vol/vol) EtOH or 2% (vol/vol) dimethyl sulfoxide (DMSO) to a maximum concentration of 10 mM (for reference, this resulted in an extinction coefficient of 24,600 ± 1300 M-1'cm-1 at a A,, of 213 nm in aqueous solution containing <0.01% DMSO). Electrophoretic mob...